Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

A Two-arm, Open-label, Single-sequence, Multiple Oral Dosings, Crossover Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of DWC202313 and DWC202314 in Healthy Adult Volunteers

This is A two-arm, open-label, single-sequence, multiple oral dosings, crossover study to evaluate the safety and the pharmacokinetic interaction of DWC202313 and DWC202314 in healthy adult volunteers.

Inclusion Criteria:

• over 19 year old

Exclusion Criteria:

• Galactose intolerance
• Lapp lactase deficiency